Akari Therapeutics News - AKTX

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
CHART Trader
Monthly Subscription
for only
$30.66
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Akari Therapeutics PLC AKTX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.01 -0.53% 1.89 1.91 1.85 1.88 1.90 20:00:00
more quote information »

Recent News

Date Time Source Heading
12/02/201908:30GLOBEAkari Therapeutics Announces Pivotal Phase III Trial Design..
11/04/201908:33GLOBEAkari Therapeutics Reports Third Quarter 2019 Financial..
10/28/201906:01EDGARNotice of Effectiveness (effect)
10/15/201917:24EDGARSecurities Registration (foreign Private Issuer) (f-1)
10/15/201917:09EDGARSecurities Registration (ads, Immediate) (f-6ef)
10/15/201907:08EDGARReport of Foreign Issuer (6-k)
10/14/201908:37GLOBEAkari Therapeutics Announces New Data from Atopic..
10/10/201909:03EDGARReport of Foreign Issuer (6-k)
10/10/201908:45GLOBEAkari Therapeutics Announces Positive Phase II Clinical Data..
10/04/201916:48EDGARStatement of Ownership (sc 13g)
9/18/201908:00GLOBEAkari Therapeutics to Participate in Ladenburg Thalmann..
9/13/201908:17EDGARReport of Foreign Issuer (6-k)
9/13/201908:00GLOBEAkari Therapeutics’ Nomacopan Granted U.S. Orphan Drug..
9/10/201908:22EDGARReport of Foreign Issuer (6-k)
9/09/201906:01EDGARNotice of Effectiveness (effect)
9/06/201917:08EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
9/06/201906:01EDGARNotice of Effectiveness (effect)
9/03/201907:00GLOBEAkari Therapeutics to Participate in Citi and H.C...
8/30/201916:04EDGARSecurities Registration (foreign Private Issuer) (f-1/a)
8/30/201916:02EDGARPost-effective Amendment to Registration Statement (pos Am)
8/30/201908:13EDGARReport of Foreign Issuer (6-k)
8/30/201907:00GLOBEAkari Therapeutics’ Nomacopan Granted U.S. Orphan Drug..
8/29/201908:29EDGARReport of Foreign Issuer (6-k)
8/29/201908:06GLOBEAkari Therapeutics Reports Second Quarter 2019 Financial..
8/19/201916:05EDGARStatement of Ownership (sc 13g)
8/14/201908:01EDGARReport of Foreign Issuer (6-k)
8/14/201908:00GLOBEAkari Therapeutics Receives FDA Fast Track Designation for..
8/09/201908:53EDGARReport of Foreign Issuer (6-k)
8/09/201908:30GLOBEAkari Therapeutics announces new data demonstrating..
8/06/201916:41EDGARSecurities Registration (foreign Private Issuer) (f-1)
7/31/201909:57GLOBEAkari Therapeutics Announces Oral Presentation of Nomacopan..
7/12/201916:33EDGARSmall Company Offering and Sale of Securities Without..
7/02/201916:26EDGARReport of Foreign Issuer (6-k)
7/02/201916:26EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/28/201916:38EDGARReport of Foreign Issuer (6-k)
6/28/201909:22GLOBEAkari Therapeutics, Plc Announces $4.5 Million Registered..
6/27/201916:34EDGARReport of Foreign Issuer (6-k)
6/25/201916:32EDGARReport of Foreign Issuer (6-k)
6/19/201916:32EDGARReport of Foreign Issuer (6-k)
6/19/201907:39GLOBEAkari Therapeutics’ Nomacopan Demonstrates Positive Early..
6/06/201917:17EDGARReport of Foreign Issuer (6-k)
5/29/201916:17EDGARReport of Foreign Issuer (6-k)
5/29/201907:45GLOBEAkari Therapeutics Reports First Quarter 2019 Financial..
5/29/201907:01EDGARReport of Foreign Issuer (6-k)
4/29/201917:26EDGARReport of Foreign Issuer (6-k)
4/26/201913:35EDGARReport of Foreign Issuer (6-k)
4/26/201908:48GLOBEAkari Therapeutics Announces Expanded Ophthalmology Program..
4/23/201917:25EDGARPost-effective Amendment to Registration Statement (pos Am)
4/23/201917:24EDGARSecurities Registration: Employee Benefit Plan (s-8)
4/23/201917:21EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
See more news about this stock »


Your Recent History
NASDAQ
AKTX
Akari Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.